Travis Coy is using his Big Pharma bona fides to prioritize business development at the diversified and growing company.
Lilly’s former M&A chief scours the landscape for potential deals as Immunocore’s new CFO
Travis Coy is using his Big Pharma bona fides to prioritize business development at the diversified and growing company.
